Compare RNW & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNW | BHC |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United Kingdom | Canada |
| Employees | 4336 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | N/A | 1996 |
| Metric | RNW | BHC |
|---|---|---|
| Price | $4.83 | $5.69 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $8.33 |
| AVG Volume (30 Days) | 823.4K | ★ 1.3M |
| Earning Date | 02-16-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | $11.50 | N/A |
| P/E Ratio | $14.63 | ★ $13.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.39 | $4.41 |
| 52 Week High | $8.24 | $8.69 |
| Indicator | RNW | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 44.41 | 58.38 |
| Support Level | $4.39 | $5.52 |
| Resistance Level | $5.58 | $6.32 |
| Average True Range (ATR) | 0.14 | 0.19 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 71.03 | 80.81 |
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.